The revenue stands at ₹1,374.84 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.56 per cent from ₹1,353.73 crore. This corresponds to a year-on-year *(YoY) growth of 19.95 per cent.
Operating Profit stands at ₹30.07 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 52.06 per cent from ₹62.73 crore. This corresponds to a year-on-year *(YoY) decline of 21.59 per cent.
PBDT stands at ₹128.34 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.84 per cent from ₹123.59 crore. This corresponds to a year-on-year *(YoY) growth of 16.17 per cent.
Profit Before Tax stands at ₹358.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.22 per cent from ₹340.81 crore. This corresponds to a year-on-year *(YoY) growth of 16.66 per cent.
Net Profit stands at ₹273.77 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.22 per cent from ₹260.19 crore. This represents a 17.56 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ajanta Pharma | 2.21% | 1.90% | 11.83% | 18.96% | 17.07% | 14.06% |
| Glaxosmi. Pharma | 1.69% | 3.60% | 13.88% | 7.06% | -4.47% | 1.77% |
| Anthem Bioscienc | 0.36% | 1.02% | 18.66% | 11.08% | -15.89% | -3.81% |
| Ipca Labs. | 0.02% | 4.04% | 4.81% | 8.30% | 6.54% | 11.15% |
| J B Chemicals & | 0.01% | 4.52% | 10.52% | 16.62% | 21.13% | 32.61% |
| Gland Pharma | 0.45% | -1.22% | 8.26% | 1.10% | -5.94% | 12.19% |
| Emcure Pharma | -0.03% | -0.40% | -3.67% | 2.34% | -2.53% | 46.73% |
Chairman (Non-Executive) : Mannalal B Agrawal
Vice Chairman : Madhusudan B Agrawal
Managing Director : Yogesh Agrawal
Vice President & Company Secretary : Gaurang Shah
Joint Managing Director : Rajesh M Agrawal
Independent Director : David Rasquinha
Independent Director : Medha Joshi
Independent Director : Simi Thapar
Independent Director : Rajesh Shashikant Dalal